Member Info for Lostapound

I said a while back that the trial is currently waiting for the Made transfer to complete before next patients get chosen and injected. By my calculations, that would put us to early March time, using only known and publicly available information to us in the RNS and Made's own transfers times etc, etc.

Financing can come anytime. I don't know if 3 patients data is enough for big pharmas to get involved. Again, no one outside of the trial knows exactly what the data is showing. We only have Vlad's snippets in various RNSs.

No one outside of trials knows for certain.

A listed biotech or pharma company must issue an RNS only if the event is “material” to the company under UK Market Abuse Regulation (MAR).

Material.

A patient death can be material if:

- It is unexpected and suggests a safety signal.

- It leads to a clinical hold, trial suspension, or protocol change.

- It threatens the viability of the drug, trial, or company.

- Regulators intervene in a way that affects timelines or outcomes.

In these cases, companies typically issue an RNS because failing to do so could be considered withholding price‑sensitive information.

This aligns with UK transparency expectations for clinical trials and regulatory oversight.

A death does not automatically trigger an RNS if:

- The death is expected within the disease population (e.g., oncology, late‑stage conditions).

- The event is assessed as unrelated to the investigational drug.

- The trial continues without regulatory action.

- The event does not materially affect the company’s prospects.

In these cases, the death is still reported to regulators and ethics bodies under clinical trial rules, but not to the stock market.

Very odd responses. This was a copy and paste question asked on Share Dive. Is that poster also shorting Hemo?

Social experiments on the witless are fun.

Can anyone explain the current cash status of Hemo in simple terms? Are they about to run out or have they got a few months left?

I hope this is one of the right questions. Can anyone point me in the direction of the video or website where Vlad stated that Made had started trial runs?

It was claimed on this board but not one person wanted to tell everyone where this snippet had come from. Strange.

17th - 24th is roughly the 12 month period of first patient injection. Possibly a time when Vlad gives an update on them.

Not this morning.

JHFH. You're in it for the financial gain as much as the rest of.

Stop using my date estimates and do your own research

MrI. You need to learn to read and follow the conversation.

I lose my cash if Hemo go pop. But then so do all other LTHs. Spose it's funny.

'Manipulated'

Another word ticked off on my MrIndia bingo card.

Not good if some investors are being fed sensitive information.

5m throughout 2026, but money possibly needed in Feb according to prospectus

MrI ramps into a selling spree, we're told, or is it rumour?

MrI "everyone not ramping is a shorter or trader"

MrI "this is Hemo's month".

MrI "price is down because of [insert non ramping poster]"

Give it a rest.

Patient 1 RNS was 24th February 2025.

About 5 weeks and we might find out what is happening with P1 on the 1st year anniversary.

@JustHereForHemo

You need to stop this projecting. The only people freaking out are the investor group and the over invested. I really don't know which of those 2 groups you fall into anymore. Maybe it's both.

I'm happy with my gamble and £1.80 average.

Have a good day. And may I suggest you try some Chamomile tea.

Bye bye chucky.

I posted a message this morning that was neither ramping nor deramping. What then happened? MrI and JHFH have lost all control. This is all anyone needs to see.

The investor group and those who are over invested only want a closed circle of ramping.

As with your obsession about an imminent £5m placing, you probably need to stop going on about traders and calling everyone traders.

See my response to MrI below.